Theranexus Société Anonyme announced that it has issues 1,930,009 common shares at a price of â¬1.28 million for the gross proceeds of â¬2.470412 million on July 12, 2023. The transactions included participation from Beyond Batten Disease Foundation and individual investors.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.11 EUR | -0.45% | -2.20% | -0.89% |
29/04 | Theranexus Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
19/04 | Theranexus: share price rises following promising trial results | CF |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.89% | 9.3M | |
+2.93% | 108B | |
+8.82% | 105B | |
+0.82% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B |
- Stock Market
- Equities
- ALTHX Stock
- News Theranexus
- Theranexus Société Anonyme announced that it has received €2.470412 million in funding